Onderneming Helius Medical Technologies, Inc. Toronto S.E.
Aandelen
HSM
US42328V6039
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Portable Neuromodulation Stimulator
93,9
%
| 1 | 98,9 % | 1 | 93,9 % | -22,24% |
Other
6,1
%
| 0 | 1,1 % | 0 | 6,1 % | +333,33% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
50,3
%
| 0 | 40,4 % | 0 | 50,3 % | +1,89% |
Canada
43,6
%
| 0 | 58,4 % | 0 | 43,6 % | -38,91% |
Global
6,1
%
| 0 | 1,1 % | 0 | 6,1 % | +333,33% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Director of Finance/CFO | 62 | 09-06-20 | |
Chief Tech/Sci/R&D Officer | 57 | 08-07-21 | |
General Counsel | - | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 18-11-14 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Blane Walter
CHM | Chairman | 53 | 29-12-15 |
Paul Buckman
BRD | Director/Board Member | 68 | 10-09-21 |
Director of Finance/CFO | 62 | 09-06-20 | |
Sherrie Perkins
BRD | Director/Board Member | 69 | 15-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 529 863 | 2 510 224 ( 99,22 %) | 0 | 99,22 % |
Bedrijfsgegevens
Helius Medical Technologies, Inc.
642 Newtown Yardley Road Suite 100
18940, Newtown
+215 944 6100
http://www.heliusmedical.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,91% | 204 mld. | |
+3,74% | 178 mld. | |
+28,89% | 156 mld. | |
+31,66% | 113 mld. | |
+1,18% | 64,26 mld. | |
+19,45% | 54,98 mld. | |
-3,44% | 47,44 mld. | |
-9,28% | 36,7 mld. | |
-0,10% | 34,84 mld. |